SARS

When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
 by Rita Rubin, MA JAMA February 14, 2024

False-Positive Results in Rapid Antigen Tests for SARS-CoV-2
 by Joshua S. Gans, PhD. Avi Goldfarb, PhD1. Ajay K. Agrawal, PhD. et al JAMA January 7, 2022

Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes
 by Brian E. McGarry, PT, PhD, Benjamin D. Sommers, MD, PhD, Andrew D. Wilcock, PhD, et al.JAMA July 14, 2023

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
 by Tanayott Thaweethai, PhD, Sarah E. Jolley, MD, MS, Elizabeth W. Karlson, MD, MS. et al. JAMA May 25, 2023

Editorial: Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many);
 by Robert Gross, MD, MSCE and Vincent Lo Re III, MD, MSCE JAMA May 25, 2023

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
 by Tanayott Thaweethai, PhD. Sarah E. Jolley, MD, MS. Elizabeth W. Karlson, MD, MS;. et al. JAMA May 25, 2023

Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram
 by Robert Gross, MD, MSCE;and Vincent Lo Re III, MD, MSCE JAMA May 25, 2023

Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children
 by Emily Harris JAMA

Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone
 by Howard Larkin JAMA February 1 2023

The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera
 by Gen Li, Zhongcheng Zhou, Peng Du, et al Precision Clinical Medicine, Volume 4, Issue 3, September 2021